- Plantar Keratoderma with Pachyonychia Likely Induced by Imatinib Mesylate
-
Kim HO, Lee BI, Lee JY, Park YM
- KMID: 2265085
- Ann Dermatol.
- 2013 Nov;25(4):526-528.
- doi: 10.5021/ad.2013.25.4.526
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
-
Lee JH, Chung JY, Jung MY, Kim CR, Park JH, Park JH, Lee JH, Lee JH, Yang JM, Lee DY
- KMID: 2265073
- Ann Dermatol.
- 2013 Nov;25(4):500-502.
- doi: 10.5021/ad.2013.25.4.500
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec(TM))
-
Cho AY, Kim DH, Im M, Lee Y, Seo YJ, Lee JH
- KMID: 2171872
- Ann Dermatol.
- 2011 Dec;23(Suppl 3):S360-S363.
- doi: 10.5021/ad.2011.23.S3.S360
Imatinib mesylate (Gleevec(TM), STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy for Postprandial Hyperglycemia in Type 2 Diabetes
-
Yoo HJ
- KMID: 1436186
- J Korean Diabetes.
- 2012 Mar;13(1):39-43.
- doi: 10.4093/jkd.2012.13.1.39
A growing body of evidence shows that effective postprandial hyperglycemia management in individuals with type 2 diabetes can reduce the risk of diabetic complications and cardiovascular diseases. Therefore, accurate monitoring... -
- CITED
-
- Close
- SHARE
-
- Close
- Rare Frameshift Mutation Cys475Tyrfs*11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
-
Park SH, Chi HS, Kwon MR, Cho YU, Jang S, Park CJ
- KMID: 2434491
- Ann Lab Med.
- 2012 Nov;32(6):452-454.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case with Coexistence of Major and Minor BCR/ABL Fusion Transcript at Lymphoblastic Crisis of Chronic Myelogenous Leukemia in Patients with Major BCR/ABL Positivity during Chronic Phase
-
Park SH, Chi HS, Cho YU, Jang S, Park CJ, Im HJ
- KMID: 1781303
- Ann Lab Med.
- 2013 Jan;33(1):80-83.
- doi: 10.3343/alm.2013.33.1.80
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Psoriasiform Drug Eruption Induced by Imatinib Mesylate (GleevecTM)
-
Bae YI, Yun SJ, Lee JB, Kim SJ, Lee SC, Won YH
- KMID: 2247824
- Korean J Dermatol.
- 2009 Jun;47(6):722-725.
Imatinib mesylate (GleevecTM, formerly known as STI571) is an oral drug that selectively inhibits bcr-abl, c-kit and platelet-derived factor receptor (PDGFR) tyrosine kinase. It has been used for treating chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Isolated Lymphoblastic Relapse of the Central Nervous System in a Patient with Chronic Myelogenous Leukemia Treated with Imatinib
-
Park MJ, Park PW, Seo YH, Kim KH, Seo JY, Jeong JH, Kim MJ, Jeong JW, Ahn JY, Park J
- KMID: 1791929
- Ann Lab Med.
- 2014 May;34(3):247-251.
- doi: 10.3343/alm.2014.34.3.247
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rapid Sequential Gain of ABL1 Kinase Domain Mutations with a Complex Karyotype in the Progression of Chronic Myelogenous Leukemia
-
Chung Y, Eom HS, Lee H, Park S, Shim H, Cho EH, Kong SY
- KMID: 1791958
- Ann Lab Med.
- 2014 Sep;34(5):399-401.
- doi: 10.3343/alm.2014.34.5.399
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Eosinophil disorders
-
Kim SY
- KMID: 2281067
- Korean J Pediatr.
- 2009 Jun;52(6):643-648.
- doi: 10.3345/kjp.2009.52.6.643
Blood eosinophilia can be classified as either familial or acquired. Familial eosinophilia is a rare autosomal dominant disorder characterized by a stable eosinophil count. Acquired eosinophilia is classified further into... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete remission of philadelphia chromosome-positive acute myeloid leukemia with imatinib mesylate
-
Jang SB, Bae SH, Jung HR, Yoon SY, Jun EJ, Kang GW, Ryoo HM
- KMID: 2259216
- Korean J Med.
- 2010 Jan;78(1):132-137.
Philadelphia chromosome-positive acute myeloid leukemia (Ph+AML) is a rare disease characterized by a poor prognosis with resistance to standard chemotherapy. We report a patient with Ph+AML with a minor BCR-ABL-positive... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Drug Eruption with Localized ExfoliativeDermatitis Induced by Imatinib Mesylate
-
Yoo KH, Rho YK, Kim JY, Li K, Seo SJ, Hong CK
- KMID: 2248087
- Korean J Dermatol.
- 2008 Oct;46(10):1435-1438.
Imatinib mesylate (Gleevec(R), formerly known as STI571) is a protein-tyrosine kinase inhibitor that inhibits the bcr-abl tyrosine kinase created by the Philadelphia chromosome abnormality in patients with chronic myeloid leukemia... -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Lung Disease
-
Chung MP
- KMID: 2319549
- Tuberc Respir Dis.
- 2011 Sep;71(3):163-171.
Recently published articles on interstitial lung disease (ILD) have focused on the accurate diagnosis of idiopathic pulmonary fibrosis (IPF), serum biomarkers, acute exacerbation of IPF, the prognostic factors of ILD... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastrointestinal Stromal Tumor
-
Kim YJ, Kim SS
- KMID: 2249541
- Korean J Helicobacter Up Gastrointest Res.
- 2011 Sep;11(2):82-89.
- doi: 10.7704/kjhugr.2011.11.2.82
Gastrointestinal stromal tumor (GIST) is a relatively rare disease accounted for less than 1% of gastrointestinal tumors. In the past, surgery is the only reliable therapy for the locoregional GISTs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Imatinib Mesylate (Gleevec(TM))-induced Lichenoid Drug Eruption Improved by Tentative Dose-reduction and Topical Steroid
-
Yang JH, Shin JW, Kim HD, Park YL, Lee SY, Whang KU
- KMID: 2303581
- Korean J Dermatol.
- 2011 Feb;49(2):155-158.
Imatinib mesylate (Gleevec(TM)) is an oral anticancer drug. It works as a selective and competitive inhibitor of tyrosine kinases such as bcr-abl protein, c-kit, and platelet-derived growth factor receptors (PDGFR).... -
- CITED
-
- Close
- SHARE
-
- Close
- Sunitinib-induced reversible posterior leukoencephalopathy syndrome after rifampin discontinuation
-
Kim MJ, Kim HJ, Bae HM, Sim SH, Lee JO, Cha Y, Lee SH
- KMID: 2258140
- Korean J Med.
- 2009 Aug;77(Suppl 1):S188-S191.
Sunitinib is an oral tyrosine kinase inhibitor with anti-angiogenic activity that is used for the treatment of advanced renal cell carcinoma and advanced gastrointestinal stromal tumors after failure on imatinib.... -
- CITED
-
- Close
- SHARE
-
- Close
- Imatinib Mesylate Induced Acquired Dermal Melanocytosis
-
Kim EK, Jung KE, Kim HS, Park YM, Kim HO, Lee JY
- KMID: 2301602
- Korean J Dermatol.
- 2012 Aug;50(8):747-750.
Dermal melanocytosis is most commonly found in the skin of Asians and other darkly pigmented populations. It is histologically characterized by the presence of ectopic melanocytes in the dermis. Mongolian... -
- CITED
-
- Close
- SHARE
-
- Close
- Imatinib-Mesylate Induced Interstitial Pneumonitis in Two CML Patients
-
Kim TH, Kim BG, Cho SW, Cho SK, Kim HJ, Yuh YJ, Kim SR
- KMID: 2319555
- Tuberc Respir Dis.
- 2011 Sep;71(3):210-215.
Imatinib mesylate, a selective inhibitor of BCR-ABL kinase activity, has demonstrated significant clinical efficacy in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It has become... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1
-
Lee KK, Kim HB, Heo MH, Kim JY, Do YR, Park KU, Song HS
- KMID: 2267780
- Korean J Med.
- 2013 Nov;85(5):535-539.
Neurofibromatosis type 1 (NF1) is a genetic disease characterized by neoplastic and non-neoplastic disorders involving tissues of neuroectodermal and mesenchymal origin. NF1 is caused by mutations in the NF1 gene,... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete Hematologic Response and Cytogenetic Remission after Imatinib and Dexamethasone Treatment of a Ph+ Precursor B-cell Acute Lymphoblastic Leukemia in Renal Transplantation Patient
-
Baek SK, Cho KS, Yang BH, Kim SY, Yoon HJ, Jeong K, Ihm CG
- KMID: 2252177
- Korean J Hematol.
- 2009 Mar;44(1):62-66.
- doi: 10.5045/kjh.2009.44.1.62
In this report, we present a case of a patient with Philadelphia chromosome-positive (Ph+) B-cell acute lymphoblastic leukemia after renal transplantation. The patient, a 65-year-old man, had received a kidney... -
- CITED
-
- Close
- SHARE
-
- Close
